Cargando…

Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective

Detalles Bibliográficos
Autores principales: Abduljalil, Jameel M., Elfiky, Abdo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628894/
https://www.ncbi.nlm.nih.gov/pubmed/36089103
http://dx.doi.org/10.1016/j.jinf.2022.09.002
_version_ 1784823287584391168
author Abduljalil, Jameel M.
Elfiky, Abdo A.
author_facet Abduljalil, Jameel M.
Elfiky, Abdo A.
author_sort Abduljalil, Jameel M.
collection PubMed
description
format Online
Article
Text
id pubmed-9628894
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-96288942022-11-03 Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective Abduljalil, Jameel M. Elfiky, Abdo A. J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-12 2022-09-08 /pmc/articles/PMC9628894/ /pubmed/36089103 http://dx.doi.org/10.1016/j.jinf.2022.09.002 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Elsevier has created a Monkeypox Information Center (https://www.elsevier.com/connect/monkeypox-information-center) in response to the declared public health emergency of international concern, with free information in English on the monkeypox virus. The Monkeypox Information Center is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its monkeypox related research that is available on the Monkeypox Information Center - including this research content - immediately available in publicly funded repositories, with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the Monkeypox Information Center remains active.
spellingShingle Letter to the Editor
Abduljalil, Jameel M.
Elfiky, Abdo A.
Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective
title Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective
title_full Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective
title_fullStr Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective
title_full_unstemmed Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective
title_short Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective
title_sort repurposing antiviral drugs against the human monkeypox virus dna-dependent rna polymerase; in silico perspective
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628894/
https://www.ncbi.nlm.nih.gov/pubmed/36089103
http://dx.doi.org/10.1016/j.jinf.2022.09.002
work_keys_str_mv AT abduljaliljameelm repurposingantiviraldrugsagainstthehumanmonkeypoxvirusdnadependentrnapolymeraseinsilicoperspective
AT elfikyabdoa repurposingantiviraldrugsagainstthehumanmonkeypoxvirusdnadependentrnapolymeraseinsilicoperspective